Sky Dominguez, a second-year student in the Medical Scientist Training Program, is currently studying the biological mechanisms underlying a sex difference in Alzheimer’s disease, as approximately two-thirds of those with the disease are women.
A novel drug called luspatercept may reduce blood transfusion burden for patients with transfusion-dependent beta-thalassemia, an inherited blood disorder.
A newly developed high-resolution brain mapping technology exceeds the lifespans of current platforms and may enhance how brain function is measured and how efficiently neurological diseases are diagnosed and treated.
Northwestern Medicine investigators have discovered that eye movements are tightly linked to learning and retrieval, according to new findings.
A specialized subset of rare immune cells called plasmacytoid dendritic cells may promote antitumor immunity, according to a Northwestern Medicine study published in the Journal of Clinical Investigation.
The Center for Community Health’s Alliance for Research in Chicagoland Communities (ARCC) hosted a virtual discussion for participants to share experiences, strategies and challenges about engaging and supporting community-engaged research partners during the COVID-19 pandemic.
First-year medical student Tazim Merchant co-organized the “Students Supporting the Community During COVID-19” project, a volunteer effort among medical students and graduate students at Feinberg that support healthcare workers, older community members and working parents in Chicago during the COVID-19 pandemic.
A team of investigators have uncovered the cellular mechanisms of a specialized group of white blood cells that help promote the development of inflammatory diseases, according to recent findings.
Tara Lagu, MD, MPH, associate director of the Institute for Healthcare Delivery and Population Science at Baystate Medical Center and the University of Massachusetts Medical School, has been named director of IPHAM’s Center for Health Services and Outcomes.
Northwestern Medicine investigators have uncovered a novel pathogenic mechanism used by the bacterium Pseudomonas aeruginosa to promote more severe infections.